The device can be compressed to half its original size and expand to conform to a variety of spaces for surgical flexibility. The bone graft can be used during spinal fusion or general orthopedic surgeries instead of using bone graft material harvested from the patient’s body.
Read the Integra LifeSciences release on the Integra Allograft Cancellous Sponge.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences Introduces New Retraction System for Minimally Invasive Spine Surgery
– DiFUSE Technologies Receives FDA Clearance for Spinal Fusion System
– Integra LifeSciences Reports 8% Increase in Total Revenue
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
